FDA.reportPublic FDA data

POTELIGEO 20 MG in 5 ML Injection

RxCUI
2054086
RxNorm name
POTELIGEO 20 MG in 5 ML Injection
Display name
POTELIGEO 20 MG in 5 ML Injection
Full name
POTELIGEO 20 MG in 5 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:25

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761051Poteligeomogamulizumab-kpkc351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
POTELIGEOMOGAMULIZUMAB-KPKCKyowa Kirin, Inc.e53960ab-42a1-40d1-9c7d-eb013fe7f18f2026-03-02Warnings, Adverse reactionsExact identifier
rxcui: 2054086

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e53960ab-42a1-40d1-9c7d-eb013fe7f18fPOTELIGEO 20 MG in 5 ML Injection [PSN] · 5 ML mogamulizumab-kpkc 4 MG/ML Injection [Poteligeo] [SBD] · 5 ML Poteligeo 4 MG/ML Injection [SY] · Poteligeo 20 MG per 5 ML Injection [SY]420These highlights do not include all the information needed to use POTELIGEO safely and effectively. See full prescribing information for POTELIGEO. POTELIGEO ® (mogamulizumab-kpkc) injection, for intravenous use Initial U.S. Approval: 201820260302